Article
Unmet needs and future directions in hypertrophic cardiomyopathy.
Progress in cardiovascular diseases - 1 Jan 2023
Kaur Simrat, Desai Milind
Abstract excerpt
Hypertrophic cardiomyopathy (HCM) is a highly treatable monogenetic disorder affecting nearly 0.2% of the population. The high burden of this disease demands suitable measures for early diagnosis and preventing as well as tackling misdiagnosis. While conventionally available therapies have been efficacious in reducing symptoms, they have not been able to change the natural history of the disease. The landscape of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
